Bofin A - Search Results

1

Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancer.

Isern AE, Manjer J, Malina J, Loman N, Mårtensson T, Bofin A, Hagen AI, Tengrup I, Landberg G, Ringberg A. Isern AE, et al. Among authors: bofin a. Br J Surg. 2011 May;98(5):659-66. doi: 10.1002/bjs.7399. Epub 2011 Feb 10. Br J Surg. 2011. PMID: 21312190

2

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients.

Engstrøm MJ, Opdahl S, Hagen AI, Romundstad PR, Akslen LA, Haugen OA, Vatten LJ, Bofin AM. Engstrøm MJ, et al. Among authors: bofin am. Breast Cancer Res Treat. 2013 Aug;140(3):463-73. doi: 10.1007/s10549-013-2647-2. Epub 2013 Jul 31. Breast Cancer Res Treat. 2013. PMID: 23901018 Free PMC article.

3

Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers.

Hagen AI, Mæhle L, Vedå N, Vetti HH, Stormorken A, Ludvigsen T, Guntvedt B, Isern AE, Schlichting E, Kleppe G, Bofin A, Gullestad HP, Møller P. Hagen AI, et al. Among authors: bofin a. Breast. 2014 Feb;23(1):38-43. doi: 10.1016/j.breast.2013.10.002. Epub 2013 Nov 5. Breast. 2014. PMID: 24210736

4

Molecular Subtypes of Breast Cancer: Long-term Incidence Trends and Prognostic Differences.

Valla M, Vatten LJ, Engstrøm MJ, Haugen OA, Akslen LA, Bjørngaard JH, Hagen AI, Ytterhus B, Bofin AM, Opdahl S. Valla M, et al. Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1625-1634. doi: 10.1158/1055-9965.EPI-16-0427. Epub 2016 Sep 26. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27672056

5

Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations.

Hagen AI, Bofin AM, Ytterhus B, Maehle LO, Kjellevold KH, Myhre HO, Møller P, Lønning PE. Hagen AI, et al. Acta Oncol. 2007;46(2):199-203. doi: 10.1080/02841860600949552. Acta Oncol. 2007. PMID: 17453369

6

The association of women's birth size with risk of molecular breast cancer subtypes: a cohort study.

Sandvei MS, Opdahl S, Valla M, Lagiou P, Vesterfjell EV, Rise TV, Overrein TS, Skjervold AH, Engstrøm MJ, Bofin AM, Vatten LJ. Sandvei MS, et al. BMC Cancer. 2021 Mar 23;21(1):299. doi: 10.1186/s12885-021-08027-9. BMC Cancer. 2021. PMID: 33757450 Free PMC article.

7

Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women.

Horn J, Opdahl S, Engstrøm MJ, Romundstad PR, Tretli S, Haugen OA, Bofin AM, Vatten LJ, Åsvold BO. Horn J, et al. Among authors: bofin am. Cancer Causes Control. 2014 Jul;25(7):881-9. doi: 10.1007/s10552-014-0388-0. Epub 2014 May 1. Cancer Causes Control. 2014. PMID: 24789514

8

Basal markers and prognosis in luminal breast cancer.

Engstrøm MJ, Valla M, Bofin AM. Engstrøm MJ, et al. Breast Cancer Res Treat. 2017 Jun;163(2):207-217. doi: 10.1007/s10549-017-4182-z. Epub 2017 Mar 3. Breast Cancer Res Treat. 2017. PMID: 28258354

9

Metabolic characterization of triple negative breast cancer.

Cao MD, Lamichhane S, Lundgren S, Bofin A, Fjøsne H, Giskeødegård GF, Bathen TF. Cao MD, et al. Among authors: bofin a. BMC Cancer. 2014 Dec 12;14:941. doi: 10.1186/1471-2407-14-941. BMC Cancer. 2014. PMID: 25495193 Free PMC article.

10

HER2 gene copy number and breast cancer-specific survival.

Biserni GB, Engstrøm MJ, Bofin AM. Biserni GB, et al. Histopathology. 2016 Nov;69(5):871-879. doi: 10.1111/his.13010. Epub 2016 Aug 2. Histopathology. 2016. PMID: 27271096

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters